Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus - Wikidata - awgldk - TriplyDB

Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus

Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus

http://www.wikidata.org/entity/Q27486103

about

A host YB-1 ribonucleoprotein complex is hijacked by hepatitis C virus for the control of NS3-dependent particle production Signal peptidase complex subunit 1 participates in the assembly of hepatitis C virus through an interaction with E2 and NS2 The hepatitis C virus glycan shield and evasion of the humoral immune response Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations (4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection Differential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic Cells Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry Hepatitis C Virus NS2 Protein Contributes to Virus Particle Assembly via Opposing Epistatic Interactions with the E1-E2 Glycoprotein and NS3-NS4A Enzyme Complexes Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles Hepatitis C Virus (HCV) Proteins Induce NADPH Oxidase 4 Expression in a Transforming Growth Factor -Dependent Manner: a New Contributor to HCV-Induced Oxidative Stress CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes Single strain isolation method for cell culture-adapted hepatitis C virus by end-point dilution and infection.Characterization of miR-122-independent propagation of HCV.Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription.Generation of a cell culture-adapted hepatitis C virus with longer half life at physiological temperature.Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions.Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity.A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses.Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles Reproduction in vitro of a quasispecies from a hepatitis C virus-infected patient and determination of factors that influence selection of a dominant species.Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations.Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry.Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.Conserved GXXXG- and S/T-like motifs in the transmembrane domains of NS4B protein are required for hepatitis C virus replication The subcellular localization of the hepatitis C virus non-structural protein NS2 is regulated by an ion channel-independent function of the p7 protein Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?A genetic interaction between the core and NS3 proteins of hepatitis C virus is essential for production of infectious virus

P2860

Q24320237-320E82DF-CF3D-4773-8B11-919AC5814653 Q24322876-948A7BE3-5D75-4E32-92F8-9EBFAF0BC57B Q27023390-A9D7E7A2-A572-4B0E-8464-FDDE54ADB298 Q27333881-36202DF9-4B27-42DD-B2DB-32AAE684DFB0 Q27468653-1F58399B-D9D4-4045-A4F4-BF776E9C539A Q27468939-A6A8FBD2-2044-4A9F-8AFE-9A4C690A8015 Q27486836-C1E655C2-0D14-46D2-8084-D403DF225176 Q27487399-72161378-2630-4D62-9E57-D35E477A1F02 Q27487947-9B4F6F77-6047-4802-A000-C9CFB0A2042F Q27488392-FAD11101-32EC-4072-99E2-C2023DFA2FFD Q27488430-F3569806-FA5F-4B11-8DFA-CB4F6FC1BEC4 Q27488616-56702A76-863E-402B-A931-FDE852A7C1F5 Q27488727-A4149783-3076-42DB-B869-9F7B2B7D2B34 Q27489514-B200DC61-21AF-42BF-BAAD-A052A12CD426 Q27490271-FC9C0B29-E9E9-48C1-87EC-0CFAE8A44A7C Q27490473-01824231-7F6E-4E58-A4D5-D8A53778E824 Q28114859-B227E343-03CD-4423-8B0E-4E37520C89E8 Q30435036-5FCB374C-E075-4CF6-B00E-BD83A32EEBD6 Q33646044-4AD8D528-257B-448E-8DD2-38B0F896647C Q33719172-D00F4F9A-BC78-4D60-880F-D581993CC795 Q33747040-15DD8193-E1EA-48A3-AD84-A89FC129917B Q33826844-6CB55C52-83CE-4DC2-91B6-C098405B22E2 Q33877381-AB0F52BA-D76B-4B75-82B1-9E410A5B05D0 Q33877391-6DE7442A-C126-4840-9285-DCFA7F377C45 Q33988533-13C6BFF0-6C26-480C-9E81-6C7F45B49784 Q34288777-93B9839E-6E72-4215-9FAF-108BCBD8DD58 Q34295953-76B00B0E-C076-45C4-87AA-21DCFFB7CCE8 Q34416559-EA7B790C-D318-412E-B518-EC8894ED8B43 Q34427768-DD611A7F-430A-48F2-A8D1-652E2C98B4A7 Q34682186-3E8F8437-EA26-4B6E-A042-38FAE129E193 Q34742576-22CE34E8-8BBF-4EC5-9193-BE6CCF5C4291 Q34742954-C8319946-B6A5-46F7-844E-928CF1CDBF95 Q34908895-71BBC1E9-463D-4E32-A7F2-1AE5B8362CED Q34936072-A4BC3F82-861F-45EB-80E8-F7DBC91A7068 Q34992715-C1352E31-D6B3-4D1D-931E-440999A7FB4B Q35077451-868978D6-2088-44E4-8F86-5DCA2411431B Q35097566-9E2EBD0E-700C-40DE-8CA1-AC36229EAA11 Q35182834-0DC98A5F-CFCE-420E-A398-6C2A2E1286C6 Q35270150-A5B250C0-208B-4350-86D8-0C2018C9EA9F Q35531477-D4DB78C3-302B-44EE-AC9C-30AB0C3D39F2

P2860

Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus

http://www.wikidata.org/entity/Q27486103

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Advantages of a single-cycle p ...... mutations of hepatitis C virus

@ast

Advantages of a single-cycle p ...... mutations of hepatitis C virus

@en

Advantages of a single-cycle p ...... mutations of hepatitis C virus

@nl

type

label

Advantages of a single-cycle p ...... mutations of hepatitis C virus

@ast

Advantages of a single-cycle p ...... mutations of hepatitis C virus

@en

Advantages of a single-cycle p ...... mutations of hepatitis C virus

@nl

prefLabel

Advantages of a single-cycle p ...... mutations of hepatitis C virus

@ast

Advantages of a single-cycle p ...... mutations of hepatitis C virus

@en

Advantages of a single-cycle p ...... mutations of hepatitis C virus

@nl

P1433

Q27486103-76AC8B04-0F9D-4602-A3B7-536A39BCFCC8

P1476

Q27486103-79DFC9EB-2A99-4A4A-B59B-BE03B5EC8C0D

P2093

Q27486103-30B3D4A0-29C7-49C6-9766-045E5266903A

Q27486103-5D54C5EF-8580-4EFB-A794-5F6A929CDA06

Q27486103-755F4B27-8B97-4DF6-9CB6-DEFF8B096ED8

Q27486103-801D90E0-3F12-4DDC-B934-281B09562EAB

Q27486103-A374D26E-7FA3-4C62-A18B-2696F7F7BD66

Q27486103-B9FC1C56-EEC7-4753-AC69-D52548F46F3C

Q27486103-EF4ADC4B-A078-4C8A-A4EF-548FA22E34CA

P2860

Q27486103-044602B4-CA67-4D7D-B511-E53F59BFEAAF

Q27486103-06CD2AFF-0877-4E4A-91B8-0FF5C86184EB

Q27486103-0C664852-43F2-4215-BF92-6BC422E74F9E

Q27486103-1C48058A-836F-4D6A-B439-00079CA48DB4

Q27486103-219E3997-E257-4022-8FB7-22B693170B97

Q27486103-2517E348-5740-400F-B2D5-C8A0847AF337

Q27486103-2A48204C-CCB7-4926-9493-4A15264534A7

Q27486103-38C176B1-D44A-448F-AEB7-13BE27F9D2EC

Q27486103-3A034FAD-5D6B-457E-9492-F71A857B7744

Q27486103-48A841E4-6E98-46BE-862D-35EB9CB4757C

P304

Q27486103-54C57025-8023-4964-A2E1-91B45B95928D

P31

Q27486103-49D50E59-EA98-4B43-B4D4-8C223DEC3E39

P3181

Q27486103-E0ED20A2-BC91-4178-8064-9332F9428F33

P356

Q27486103-911B45C4-1B45-44A7-8C40-383D38464649

P407

Q27486103-7A8806ED-C9EA-464E-99AB-85EBD3B27BCF

P433

Q27486103-EB01B584-0C29-4CCF-A71D-DB872B434BEB

P478

Q27486103-F09BB6C4-D352-4200-A234-0C2CD3E87C03

P50

Q27486103-74CE2FA8-BA4C-476B-8EEF-F2E28B43647B

P577

Q27486103-386CD043-F472-4A42-8FB2-1F181677B761

P5875

Q27486103-433C8E48-CE5B-4B73-B31A-9D587778B6E4

P698

Q27486103-7BE59D22-ACCC-4FBA-A7BC-EC9137965A00

P932

Q27486103-E0982B42-7894-4E3B-9E15-9D53FD4FD052

P3181

P356

PNAS.0800422105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Advantages of a single-cycle p ...... mutations of hepatitis C virus

@en

P2093

Jean-Christophe Meunier

http://www.w3.org/2001/XMLSchema#string

Kristina Faulk

http://www.w3.org/2001/XMLSchema#string

Robert H Purcell

http://www.w3.org/2001/XMLSchema#string

Rodney S Russell

http://www.w3.org/2001/XMLSchema#string

Ronald E Engle

http://www.w3.org/2001/XMLSchema#string

Shingo Takikawa

http://www.w3.org/2001/XMLSchema#string

Suzanne U Emerson

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.

Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.

Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.

Robust hepatitis C virus infection in vitro.

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

P304

4370-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1818011

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0800422105

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5516944

http://www.w3.org/2001/XMLSchema#string

P698

18334634

http://www.w3.org/2001/XMLSchema#string

P932

2393785

http://www.w3.org/2001/XMLSchema#string